$2.36 Billion is the total value of NEA Management Company, LLC's 54 reported holdings in Q3 2020. The portfolio turnover from Q2 2020 to Q3 2020 was 25.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
SPT | Sell | SPROUT SOCIAL INC | $215,449,000 | -11.8% | 5,596,080 | -38.1% | 9.12% | -7.1% |
CRSP | Sell | CRISPR THERAPEUTICS AGnamen akt | $132,988,000 | -13.4% | 1,590,002 | -23.9% | 5.63% | -8.8% |
MRSN | Sell | MERSANA THERAPEUTICS INC | $110,966,000 | -40.4% | 5,959,520 | -25.1% | 4.70% | -37.3% |
NET | Sell | CLOUDFLARE INC | $11,347,000 | -92.2% | 2,763,583 | -31.9% | 0.48% | -91.8% |
SENS | Sell | SENSEONICS HOLDINGS INC | $5,520,000 | -11.7% | 14,153,201 | -11.7% | 0.23% | -6.8% |
SNSS | Sell | SUNESIS PHARMACEUTICALS INC | $162,000 | -52.6% | 129,827 | -90.0% | 0.01% | -50.0% |
RIGL | Exit | RIGEL PHARMACEUTICALS INC | $0 | – | -3,243,150 | -100.0% | -0.24% | – |
DZSI | Exit | DASAN ZHONE SOLUTIONS INC | $0 | – | -956,255 | -100.0% | -0.34% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-11-06
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
GLYCOMIMETICS INC | 39 | Q3 2023 | 7.6% |
AURINIA PHARMACEUTICALS INC | 37 | Q3 2023 | 5.0% |
CHAMPIONS ONCOLOGY INC | 33 | Q3 2023 | 1.2% |
LEXICON PHARMACEUTICALS INC | 32 | Q3 2023 | 2.0% |
ADAPTIMMUNE THERAPEUTICS PLC | 31 | Q3 2023 | 9.3% |
TREVENA INC | 31 | Q3 2021 | 3.3% |
AKARI THERAPEUTICS PLC | 31 | Q2 2023 | 0.3% |
ARDELYX INC | 29 | Q3 2021 | 11.9% |
RIGEL PHARMACEUTICALS INC | 29 | Q2 2020 | 0.6% |
EPIZYME INC | 28 | Q1 2020 | 9.6% |
View NEA Management Company, LLC's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-14 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-11 |
13F-HR | 2023-05-15 |
13F-HR | 2023-02-10 |
13F-HR | 2022-11-14 |
13F-HR | 2022-08-15 |
13F-HR | 2022-05-16 |
13F-HR | 2022-02-14 |
13F-HR | 2021-11-12 |
View NEA Management Company, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.